Facts and Figures | Singapore Economic Development Board

Facts and Figures

In 2010, Singapore, the biopharmaceutical sector contributed about S$19 billion in output and over 5,300 jobs.
Seven of the world's top pharmaceutical and biotechnology companies have invested in 30 commercial-scale manufacturing facilities in Singapore. They include Abbott, GlaxoSmithKline, Lonza, Merck Sharp & Dohme, Novartis, Pfizer, Roche and Sanofi. Validated by regulatory authorities from the US, Europe and Japan, these plants produce innovative medicines for the global market.
Eight of the top 10 pharmaceutical have their regional headquarters in Singapore, from which to drive business expansion in Asia. Global leaders that have established strategic headquarter functions in Singapore include Johnson & Johnson, Pfizer, GlaxoSmithKline (GSK), Merck, Sharpe & Dohme, Bayer, Roche, Sanofi and AstraZeneca.
Singapore hosts cosmopolitan research teams in both public-sector research institutes and corporate R&D labs. The Novartis Institute for Tropical Diseases, for example, houses more than 100 researchers from 18 nationalities.
Companies can leverage Singapore’s pro-business environment to commence operations within short lead time. It takes 15 minutes to register a business online, 3 weeks to receive approval for clinical trials, and 24-36 months for a manufacturing facility to be operational

Back